European Opportunities Loom For Value Added Medicines
But Sales Still Lag US, With EU Legislative Review Set To Address Sector’s Need For Reform
• By David Wallace
Panelists discussed opportunities and obstacles for value added medicines at Medicines for Europe’s fifth annual conference • Source: Medicines for Europe
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
